New Delhi: Hyderabad-based drug maker Bharat Biotech has received regulatory approval to start a Phase I clinical trial to test…
Hyderabad: Reddy Laboratory on Friday said he was discussing with Indian drug regulators to bring Sputnik M Russia, Covid-19 vaccine…
New Delhi: Medication Controller General India (DCGI) on Friday gave permission to Bharat Biotech to trial in an intranasal amplifier…
New Delhi: Indian Drug Regulator, Drug Controller General of India (DCGI), on Thursday gave approval for the vaccine Covid regular…
Varanasi: Virology and Head of Molecular Biology Unit, Institute of Medical Sciences, University of Banaras Hindu (IMS-BHU), Prof.Sunit Kumar Singh…
Bhubaneswar: The first phase cost of rebuilding SCB Medical College and Hospital, Cuttack, has increased around RS 1,000 Crore after…
New Delhi: The first MRNA Messenger vaccine in the country is expected to start a trial in humans in February.Pune-based…
New Delhi: The use of molnupiravir anti-virus drugs has a risk that must be warned, health officials say it underlines…
Bengaluru: The doctor has the top new antivirus drug molnupiravir, launched on January 3 to treat Covid-19, after recent comments…
Mumbai: A clinical study of the second generation Covid-19 vaccine candidate based in the US has begun in India.In an…
